Pain
In this section you will find Therapeutics Diseases & Conditions Pain market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
8 Item(s)
per page
-
World Pain Relieving Drug Market 2011-2021
€1,968.00Published by Visiongain on Apr 27th, 2011we show you revenue growth opportunities there What are the prospects for the pain treatment market from 2011? Our new report shows you its revenue potential from 2011 to 2021... Learn More -
Neuropathic Pain: Competing Treatments and Market Entry Considerations
€7,190.00Published by BioPharm Reports on Jun 1st, 2010This report presents the findings of a global study of current therapeutic approaches to the treatment of Neuropathic Pain (NP). These findings were made following the participation of more than... Learn More -
Neuropathic Pain: Emerging Drugs and Current Treatment Practices
€2,300.00Published by BioPharm Reports on Feb 15th, 2010This report presents a comprehensive update on emerging drug candidates for neuropathic pain, (NP) together with the findings of global survey on current treatment practices in the clinic, following the... Learn More -
Neuropathic Pain: A Global Survey of Treatment Practices
€2,384.00Published by BioPharm Reports on Jan 20th, 2010This report presents the findings of a global survey on current therapeutic approaches to the treatment of Neuropathic Pain (NP). These findings were made following the participation of more than... Learn More -
The Global Pain Market, 2008-2023
€1,739.00Published by Visiongain on Nov 13th, 2008This report provides analysis and forecasts for the overall pain market and its principal subdivisions, as well as for leading products within those categories. Learn More -
The Anti-Migraine Market 2007-2022
€1,739.00Published by Visiongain on Nov 13th, 2007This report examines the market critically through a comprehensive review of available information. Sources include industrial databases, commercial news, published reports, economic research and consultation with experts. Learn More -
Rimonabant: The first of the Cannabinoid blockbusters
€1,739.00Published by Visiongain on Jun 15th, 2007This 190+ paged report features over 25 tables, and over 40 graphs and figures. The latest news, insights and analysis of the latest developments are included, with an in depth review of the cannabinoids market. Learn More -
Neurodegenerative Disease Drug Market Analysis & Forecasts 2007
€1,739.00Published by Visiongain on Jun 15th, 2007This report provides up-to-date analysis of present and future market illustrated by substantial number of charts and figures. It also discusses strategies employed by key players in the industries. This is a must buy report, as it will provide you with useful information on business opportunities in the big and niche markets. Learn More
8 Item(s)
per page